AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Tibial IMN Vs. Tibial Micromotion IMN

RecruitingNAAges 18 Years - anyAllUniversity of Chicago
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Our null hypothesis is that micromotion tibial intramedullary fixation (IMFN) does not impact union or complication rates when compared to standard of care treatment with non-micromotion tibial nail fixation. There are no current or past randomized controlled trials comparing these fixation techniques to one another. There is good data supporting both the use of intramedullary fixation for tibial fractures alone, and in high-risk patient populations (open fractures, GSW tibial fractures). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to pe

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age 18 or older 2. Unstable tibial fracture recommended for surgical intervention Exclusion Criteria: 1. Patients not meeting inclusion criteria (Stable fracture patterns) 2. Previously non-ambulatory patients 3. Delayed presentation of fracture (\>4 weeks) 4. Fractures that the treating surgeon indicates requires additional fixation strategies to achieve stability 5. Patients with an active infection or wound at the surgical site 6. Utilizing worker's compensation at the time of screening 7. Any previous ligament or fracture surgery on the index site 8. Inflammatory rheumatic disease or other rheumatic disease 9. Immune compromised patients (hepatitis, HIV, etc.) 10. Non-English-speaking patients 11. Unwilling or unable to participate or follow study protocol
๐Ÿ’Š

What it tests

  • Intramedullary tibial Nail
  • Intermedullary nail
๐Ÿ“

Where

1 site
University of Chicago
Chicago, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy